Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 1
2016 2
2017 1
2018 1
2019 3
2020 4
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Wnt Signalling in Acute Myeloid Leukaemia.
Gruszka AM, Valli D, Alcalay M. Gruszka AM, et al. Cells. 2019 Nov 7;8(11):1403. doi: 10.3390/cells8111403. Cells. 2019. PMID: 31703382 Free PMC article. Review.
Adhesion Deregulation in Acute Myeloid Leukaemia.
Gruszka AM, Valli D, Restelli C, Alcalay M. Gruszka AM, et al. Cells. 2019 Jan 17;8(1):66. doi: 10.3390/cells8010066. Cells. 2019. PMID: 30658474 Free PMC article. Review.
CAR T cells targeting options in the fight against multiple myeloma.
Nicolini F, Bravaccini S, Mazza M, Gruszka AM, Tazzari M, MartÍn-Antonio B, Juan M, Ibrahim T, Maltoni R, Martinelli G, Cerchione C. Nicolini F, et al. Among authors: gruszka am. Panminerva Med. 2021 Mar;63(1):37-45. doi: 10.23736/S0031-0808.20.04146-4. Epub 2020 Sep 21. Panminerva Med. 2021. PMID: 32955187 Free article. Review.
HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia.
Spreafico M, Gruszka AM, Valli D, Mazzola M, Deflorian G, Quintè A, Totaro MG, Battaglia C, Alcalay M, Marozzi A, Pistocchi A. Spreafico M, et al. Among authors: gruszka am. Front Cell Dev Biol. 2020 Sep 4;8:844. doi: 10.3389/fcell.2020.00844. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33015043 Free PMC article.
Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.
Jurczak W, Gruszka AM, Sowa Staszczak A, Dlugosz-Danecka M, Szostek M, Zimowska-Curylo D, Giza A, Krawczyk K, Jakobczyk M, Hubalewska-Dydejczyk A, Szymczyk M, Wróbel T, Knopińska-Posłuszny W, Kisiel E, Skotnicki A, Zinzani PL. Jurczak W, et al. Among authors: gruszka am. Leuk Lymphoma. 2019 Nov;60(11):2689-2696. doi: 10.1080/10428194.2019.1602261. Epub 2019 Apr 9. Leuk Lymphoma. 2019. PMID: 30961415 Clinical Trial.
13 results